Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

4.67 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 509.023504.958490.653478.841478.01471.945466.413451.147443.009442.955450.534414.07411.276436.112417.16422.302366.003351.577355.223
Cost of Revenue 349.324349.524347.711333.677330.746316.69321.948322.372308.426303.95305.708289.68271.534289.523285.477296.087251.873244.948247.682
Gross Profit 159.699155.434142.942145.164147.264155.255144.465128.775134.583139.005144.826124.39139.742146.589131.683126.215114.13106.629107.541
Gross Profit Ratio 0.3140.3080.2910.3030.3080.3290.310.2850.3040.3140.3210.30.340.3360.3160.2990.3120.3030.303
Reseach & Development Expenses 0000000000000000000
General & Administrative Expenses 118.075116.359117.179107.251117.96891.25560.773110.679119.395125.2125.31106.633114.243110.12196.77199.2892.13477.86985.491
Selling & Marketing Expenses 0-0.224-2.6895.01900003.3623.524000000000
SG&A 118.075116.135114.49112.27117.96891.25560.773110.679122.757116.319125.31106.633114.243110.12196.77199.2892.13477.86985.491
Other Expenses 7.6-0.091-2.32-0.5610.02425.1694.11317.3850-0.0015.6491.1270.0550.0010.159-0.205-0.110.0141.791
Operating Expenses 125.675116.226116.81112.831118.052117.79564.886128.064105.161116.32130.959111.683119.388115.291101.619103.60496.74382.6989.674
Operating Income 34.02439.20826.13232.333-76.35237.49217.639-1.7584.78722.68513.776-113.04818.34730.29428.29617.72612.877-51.95717.867
Operating Income Ratio 0.0670.0780.0530.068-0.160.0790.038-0.0040.0110.0510.031-0.2730.0450.0690.0680.0420.035-0.1480.05
Total Other Income Expenses Net -61.356-33.147-21.376-60.888-25.406-12.703-48.071-34.68516.842-17.8514.155-9.064-17.357-28.855-22.189-25.057-20.75-23.34120.901
Income Before Tax -27.3323.9791.49-31.595-101.75824.789-30.432-239.14321.629-474.23127.931-122.1120.991.4396.107-7.331-7.873-75.29838.768
Income Before Tax Ratio -0.0540.0080.003-0.066-0.2130.053-0.065-0.530.049-1.0710.062-0.2950.0020.0030.015-0.017-0.022-0.2140.109
Income Tax Expense 15.511-9.92712.662-5.8590.631-0.811.566-1.3642.669-0.3442.5974.08-1.10.1790.3092.401-0.4712.2551.131
Net Income -42.84313.906-11.172-25.736-102.38925.599-31.998-237.77924.298-473.88725.334-126.1922.091.265.798-9.732-7.402-77.55337.637
Net Income Ratio -0.0840.028-0.023-0.054-0.2140.054-0.069-0.5270.055-1.070.056-0.3050.0050.0030.014-0.023-0.02-0.2210.106
EPS -0.220.072-0.058-0.13-0.540.14-0.17-1.280.13-2.560.14-0.680.010.010.032-0.068-0.041-0.430.21
EPS Diluted -0.220.071-0.058-0.13-0.540.13-0.17-1.280.13-2.560.14-0.670.010.010.032-0.068-0.041-0.430.21
EBITDA -95.01251.05935.27715.223-54.88170.20313.803-195.8489.704-441.06560.307-97.8320.06936.46838.69824.58124.692-48.81467.137
EBITDA Ratio -0.1870.0920.0720.0820.0760.140.0520.0170.0220.0740.050.0560.0670.0970.0930.0720.0670.090.189